Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial‐onset seizures: Results of a phase III , double‐blind, randomized, placebo‐controlled trial-Reference-Cited by-同舟云学术

Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial‐onset seizures: Results of a phase III , double‐blind, randomized, placebo‐controlled trial

Published:2014-12-22 Issue:2 Volume:56 Page:244-253
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Sperling Michael R.¹,Abou‐Khalil Bassel²,Harvey Jay³,Rogin Joanne B.⁴,Biraben Arnaud⁵,Galimberti Carlo A.⁶,Kowacs Pedro A.⁷,Hong Seung Bong⁸,Cheng Hailong⁹,Blum David⁹,Nunes Teresa¹⁰,Soares‐da‐Silva Patrício¹⁰¹¹,

Affiliation:

1. Thomas Jefferson University Philadelphia Pennsylvania U.S.A

2. Vanderbilt University Medical Center Nashville Tennessee U.S.A

3. Texas Epilepsy Group Dallas Texas U.S.A

4. Midwest Center for Seizure Disorders Minneapolis Clinic of Neurology Golden Valley Minnesota U.S.A

5. C.H.U. de Rennes Rennes France

6. I.R.C.C.S. C. Mondino National Neurological Institute Pavia Italy

7. Curitiba Neurological Institute Curitiba Brazil

8. Samsung Medical Center Samsung Biomedical Research Institute Sungkyunkwan University School of Medicine Seoul South Korea

9. Sunovion Pharmaceuticals Inc. Marlborough Massachusetts U.S.A

10. BIAL‐Portela & C^a S.A. S. Mamede do Coronado Portugal

11. MedInUP – Center for Drug Discovery and Innovative Medicines University of Porto Porto Portugal